Peristomal pyoderma gangrenosum successfully treated with cyclosporine

Shoko Urano, Jinnroh Abe, Hirotoshi Kikuchi

Article ID: 1474
Vol 6, Issue 2, 2022

VIEWS - 824 (Abstract) 358 (PDF)

Abstract


Peristomal pyoderma gangrenosum (PPG) is an uncommon subtype of pyoderma gangrenosum. We describe a 74-year-old woman without inflammatory bowel disease (IBD) who developed PG around the jejunostomy and was successfully treated with cyclosporine. In our case, irritations by a lumbar corset and repeated sutures around the jejunostomy seemed to have caused pathergy reaction. It is noteworthy that 20% of PPG patients do not have IBD and therefore patients presenting PPG without IBD should not be overlooked.

Keywords


Peristomal Pyoderma Gangrenosum; Jejunostomy; Pathergy; Cyclosporine

Full Text:

PDF


References


1. McGarity WC, Robertson DB, McKeown PP, et al. Pyoderma gangrenosum at the parastomal site in patients with Crohn’s disease. Archives of Surgery 1984; 119(10): 1186–1188. doi: 10.1001/archsurg.1984.01390220064014

2. Barbosa NS, Tolkachjov SN, el-Azhary RA, et al. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013. Journal of the American Academy of Dermatology 2016; 75: 931–939. doi: 10.1016/j.jaad.2016.05.044

3. Afifi L, Sanchez IM, Wallace MM, et al. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review. Journal of the American Academy of Dermatology 2018; 78: 1195–1204. doi: 10.1016/j.jaad.2017.12.049

4. Davis C, Wright B. Healing of a pyoderma gangrenosum at the site of a percutaneous endoscopically sited gastrostomy tube without tube removal. Case Reports 2014; 2014: bcr2014204301. doi: 10.1136/bcr-2014-204301

5. Lockenhofer F, Wollina U, Salva KA, et al. The PARAELSUS score: A novel diagnostic tool for pyoderma gangrenosum. British Journal of Dermatology 2019; 180: 615–620. doi: 10.1111/bjd.16401

6. Hashizume H, Kageyama R, Umayahara T, et al. A case of pyoderma arthritis, pyoderma gangrenosumu, and acne (PAPA) syndrome successfully treated with combination therapy of corticosteroids, cyclosporine, and colchicine. Trends in Immunotherapy 2018. doi: 10.24294/ti.v2.i2.719

7. Okuno A, Kanda Y, Nakano H, et al. Therapeutic effects of cyclosporine on Hailey-Hailey disease. Trends in Immunotherapy 2019; 3(1): 58–61. doi: 10.24294/ti.v3.i1.1140




DOI: https://doi.org/10.24294/ti.v6.i2.1474

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Shoko Urano, Jinnroh Abe, Hirotoshi Kikuchi

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This site is licensed under a Creative Commons Attribution 4.0 International License.